142 related articles for article (PubMed ID: 31910120)
1. Radiation Biomarkers: Can Small Businesses Drive Accurate Radiation Precision Medicine?
Prasanna PGS; Narayanan D; Zhang K; Rahbar A; Coleman CN; Vikram B
Radiat Res; 2020 Mar; 193(3):199-208. PubMed ID: 31910120
[TBL] [Abstract][Full Text] [Related]
2. Decreasing the Toxicity of Radiation Therapy: Radioprotectors and Radiomitigators Being Developed by the National Cancer Institute Through Small Business Innovation Research Contracts.
Zakeri K; Narayanan D; Vikram B; Evans G; Coleman CN; Prasanna PGS
Int J Radiat Oncol Biol Phys; 2019 May; 104(1):188-196. PubMed ID: 30583040
[TBL] [Abstract][Full Text] [Related]
3. Development of Novel Radiosensitizers through the National Cancer Institute's Small Business Innovation Research Program.
Zakeri K; Narayanan D; Prasanna PGS; Vikram B; Buchsbaum JC
Radiat Res; 2020 May; 193(5):425-434. PubMed ID: 32216707
[TBL] [Abstract][Full Text] [Related]
4. Advancing Targeted Radionuclide Therapy Through the National Cancer Institute's Small Business Innovation Research Pathway.
Zakeri K; Narayanan D; Evans G; Prasanna P; Buchsbaum JC; Vikram B; Capala J
J Nucl Med; 2019 Jan; 60(1):41-49. PubMed ID: 30030338
[TBL] [Abstract][Full Text] [Related]
5. INGN 201: Ad-p53, Ad5CMV-p53, adenoviral p53, p53 gene therapy--introgen, RPR/INGN 201.
Drugs R D; 2007; 8(3):176-87. PubMed ID: 17472413
[TBL] [Abstract][Full Text] [Related]
6. Radioprotectors and Radiomitigators for Improving Radiation Therapy: The Small Business Innovation Research (SBIR) Gateway for Accelerating Clinical Translation.
Prasanna PG; Narayanan D; Hallett K; Bernhard EJ; Ahmed MM; Evans G; Vikram B; Weingarten M; Coleman CN
Radiat Res; 2015 Sep; 184(3):235-48. PubMed ID: 26284423
[TBL] [Abstract][Full Text] [Related]
7. Efaproxiral: GSJ 61, JP 4, KDD 86, RS 4, RSR 13.
Drugs R D; 2005; 6(3):178-85. PubMed ID: 15869322
[TBL] [Abstract][Full Text] [Related]
8. Lessons learned from independent central review.
Ford R; Schwartz L; Dancey J; Dodd LE; Eisenhauer EA; Gwyther S; Rubinstein L; Sargent D; Shankar L; Therasse P; Verweij J
Eur J Cancer; 2009 Jan; 45(2):268-74. PubMed ID: 19101138
[TBL] [Abstract][Full Text] [Related]
9. Radiogenomics - current status, challenges and future directions.
Andreassen CN; Schack LM; Laursen LV; Alsner J
Cancer Lett; 2016 Nov; 382(1):127-136. PubMed ID: 26828014
[TBL] [Abstract][Full Text] [Related]
10. Recent advances in light ion radiation therapy.
Brahme A
Int J Radiat Oncol Biol Phys; 2004 Feb; 58(2):603-16. PubMed ID: 14751534
[TBL] [Abstract][Full Text] [Related]
11. Integrated proteo-genomic approach for early diagnosis and prognosis of cancer.
Shukla HD; Mahmood J; Vujaskovic Z
Cancer Lett; 2015 Dec; 369(1):28-36. PubMed ID: 26276717
[TBL] [Abstract][Full Text] [Related]
12. How Advances in Imaging Will Affect Precision Radiation Oncology.
Jaffray DA; Das S; Jacobs PM; Jeraj R; Lambin P
Int J Radiat Oncol Biol Phys; 2018 Jun; 101(2):292-298. PubMed ID: 29726358
[TBL] [Abstract][Full Text] [Related]
13. CARE program: NCI and FDA interagency collaborations to support oncology small business entrepreneurs.
Pond MA; Narayanan D; Zhang K; Fau D; Summers J; Carranza D; Weingarten M
Clin Transl Sci; 2023 Mar; 16(3):412-421. PubMed ID: 36601678
[TBL] [Abstract][Full Text] [Related]
14. Sipuleucel-T: APC 8015, APC-8015, prostate cancer vaccine--Dendreon.
Drugs R D; 2006; 7(3):197-201. PubMed ID: 16752945
[TBL] [Abstract][Full Text] [Related]
15. Regarding: Rosenthal DI, Glatstein E. "We've Got a Treatment, but What's the Disease?" The Oncologist 1996;1.
Lunsford LD; Flickinger JC; Larson D
Oncologist; 1997; 2(1):59-61. PubMed ID: 10388030
[TBL] [Abstract][Full Text] [Related]
16. Erlotinib: CP 358774, NSC 718781, OSI 774, R 1415.
Adis International Ltd
Drugs R D; 2003; 4(4):243-8. PubMed ID: 12848590
[TBL] [Abstract][Full Text] [Related]
17. Satraplatin: BMS 182751, BMY 45594, JM 216.
Drugs R D; 2007; 8(2):125-32. PubMed ID: 17324011
[TBL] [Abstract][Full Text] [Related]
18. The INTRABEAM® Photon Radiotherapy System for the adjuvant treatment of early breast cancer: a systematic review and economic evaluation.
Picot J; Copley V; Colquitt JL; Kalita N; Hartwell D; Bryant J
Health Technol Assess; 2015 Aug; 19(69):1-190. PubMed ID: 26323045
[TBL] [Abstract][Full Text] [Related]
19. Rubitecan: 9-NC, 9-Nitro-20(S)-camptothecin, 9-nitro-camptothecin, 9-nitrocamptothecin, RFS 2000, RFS2000.
Drugs R D; 2004; 5(5):305-11. PubMed ID: 15357630
[TBL] [Abstract][Full Text] [Related]
20. Next-generation sequencing: hype and hope for development of personalized radiation therapy?
Tinhofer I; Niehr F; Konschak R; Liebs S; Munz M; Stenzinger A; Weichert W; Keilholz U; Budach V
Radiat Oncol; 2015 Aug; 10():183. PubMed ID: 26316159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
